Ani Pharmaceuticals (ANIP) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Ani Pharmaceuticals (ANIP) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | -58.34% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | -14.91% |
| 10 | Ani Pharmaceuticals | 1.65 Bn | 1.34 Bn | 143.88 Mn | 78.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.42% |
| Dec 31, 2025 | 499.00% |
| Sep 30, 2025 | 289.26% |
| Jun 30, 2025 | 2.03% |
| Mar 31, 2025 | -48.92% |
| Dec 31, 2024 | -254.39% |
| Sep 30, 2024 | -153.18% |
| Jun 30, 2024 | -46.68% |
| Mar 31, 2024 | 155.67% |
| Dec 31, 2023 | 125.50% |
| Sep 30, 2023 | 630.63% |
| Jun 30, 2023 | 241.30% |
| Mar 31, 2023 | 177.94% |
| Dec 31, 2022 | 106.20% |
| Sep 30, 2022 | -17.29% |
| Jun 30, 2022 | 28.50% |
| Mar 31, 2022 | -612.83% |
| Dec 31, 2021 | -2,952.31% |
| Sep 30, 2021 | -234.68% |
| Jun 30, 2021 | -121.66% |